Abiopharma

Alnylam Pharmaceuticals Announces Changes to Board of Directors

Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

Inspire Medical Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – INSP

Virax Biolabs CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Relmada Therapeutics Announces Presentation of NDV-01 Phase 2 Data at the Society for Urologic Oncology

Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy

Veeva AI Agents Now Available to Increase Productivity and Customer Centricity

Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM

Vicarious Surgical Inc. - Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook